CSPC Pharmaceutical Group Limited - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
CSPCY Over the counter 8081 www.cspc.com.hk

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CSPC Pharmaceutical Group Limited

The Evolving EGFR NSCLC Market: 8 Emerging Late-stage Therapies to Watch | DelveInsight - Jun 1st, 2026 6:31 am
CSPC’s SYS6051 Trial Approval Adds New Angle To Valuation Story - Apr 22nd, 2026 3:04 pm
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation - Apr 22nd, 2026 12:10 am
Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint - Apr 1st, 2026 8:44 am
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer - Mar 23rd, 2026 7:32 pm
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003 - Feb 14th, 2026 5:58 am
AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC - Feb 2nd, 2026 9:00 am
CSPC AstraZeneca Deal Recasts Role In Global Obesity And Diabetes Therapies - Feb 1st, 2026 8:08 am
AstraZeneca Agrees Up to $18.5 Billion Obesity Drug Deal in China - Jan 30th, 2026 5:52 am
Trending tickers: Apple, Microsoft, Sandisk, Caterpillar and AstraZeneca - Jan 30th, 2026 2:43 am
AstraZeneca secures tie-up with Chinese firm for weight loss drugs - Jan 30th, 2026 1:18 am
AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC - Jan 30th, 2026 12:36 am
Is CSPC Pharmaceutical Group (SEHK:1093) Still Attractive After A 129% One-Year Share Price Surge - Jan 27th, 2026 3:07 pm
Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology - Jan 26th, 2026 6:58 pm
Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China - Dec 30th, 2025 7:49 am
Novo Nordisk Cuts Wegovy Prices in China Ahead of Patent Expiration - Dec 29th, 2025 10:45 am
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC - Dec 19th, 2025 9:54 pm
How Regulatory Approval for CSPC Pharmaceutical’s First C5 siRNA Therapy (SEHK:1093) Has Changed Its Investment Story - Nov 7th, 2025 4:17 am
Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates - Nov 4th, 2025 5:00 am
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for Colorectal Cancer - Oct 26th, 2025 7:51 pm